NCCAM Intramural, International Research Directors Named
This article was originally published in The Tan Sheet
Executive Summary
The National Center for Complementary & Alternative's Medicine's new intramural research program is likely to reflect, in part, its clinical director's expertise in the endocrinology of aging.
You may also be interested in...
NCCAM DHEA/Aging Trials In Development, Intramural Director Says
NCCAM's Division of Intramural Research is composing study protocols to look at DHEA's effect on age-related health defects, Clinical Director Marc Blackman, MD, said at an advisory council meeting in Bethesda, Md. May 31.
Duke St. John's Wort Study Findings Imminent - NCCAM's Straus
Results of a National Institutes of Health-funded study on the active constituent of St. John's wort's efficacy in treating depression are due shortly, according to National Center for Complementary & Alternative Medicine Director Stephen Straus, MD.
Hiring Freeze Will Affect FDA Commissioner, ORM Director Appointments
Acting FDA Commissioner Bernard Schwetz, PhD, will continue to make funding the agency's science base a top priority, he stresses in a Jan. 22 email to agency staff.